Session 2: Molecular Diagnostics: Molecular Diagnostics: Chairman's Introduction JOHN F. LECHNER, Office of Technology for Diagnostics Systems, Bayer Diagnostics, Berkeley, California 94702

Sign In to gain access to subscriptions and/or personal tools.

This Article

	Free Full Text (Free PDF) Free
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map

Services

	Email this article to a friend
	Similar articles in this journal
	Alert me to new issues of the journal
	Add to Saved Citations
	Download to citation manager
	Request Permissions
	Request Reprints
	Add to My Marked Citations

Citing Articles

	Citing Articles via Google Scholar
	Citing Articles via Scopus

Google Scholar

	Search for Related Content

Social Bookmarking

	What's this?

Session 2: Molecular Diagnostics

References

Allegra, C. and D. Sargent (2003). "Molecular Diagnostics: Assays, Tissues, Progress, and Pitfalls." J Clin Oncol 21: 395—6.[Free Full Text]

Bertucci, F., P. Viens, P. Hingamp, et al. (2003). "Breast Cancer Revisited Using DNA Array-Based Gene Expression Profiling." Int J Cancer 103: 565—71.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Bertucci, F., P. Viens, R. Tagett, et al. (2003). "DNA Arrays in Clinical Oncology: Promises and Challenges." Lab Invest 83: 305—16.[Web of Science][Medline] [Order article via Infotrieve]

Bustin, S.A. and S. Dorudi (2002). "The Value of Microarray Techniques for Quantitative Gene Profiling in Molecular Diagnostics." Trends Mol Med 8: 269—72.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Ciro, M., A.P. Bracken, and K. Helin (2003). "Profiling Cancer." Curr Opin Cell Biol 15: 213—20.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Farkas, D.H. (2002). "Molecular Diagnostics: the Best is Yet to Come." Trends Mol Med 8: 245.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Fortina, P., S. Surrey, and L.J. Kricka (2002). "Molecular Diagnostics: Hurdles for Clinical Implementation." Trends Mol Med 8: 264—6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Goessl, C. (2003). "Noninvasive Molecular Detection of Cancer—The Bench and the Bedside." Curr Med Chem 10: 691—706.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Hampton, G.M. and H.F. Frierson (2003). "Classifying Human Cancer by Analysis of Gene Expression." Trends Mol Med 9: 5—10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Iacopetta, B. (2003). "Aberrant DNA Methylation: Have We Entered the Era of More Than One Type of Colorectal Cancer?" Am J Pathol 162: 1043—5.[Free Full Text]

Johnson, J.A. and W.E. Evans (2002). "Molecular Diagnostics as a Predictive Tool: Genetics of Drug Efficacy and Toxicity." Trends Mol Med 8: 300—5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Ladanyi, M., W.C. Chan, T.J. Triche, and W.L. Gerald (2001). "Expression Profiling of Human Tumors: The End of Surgical Pathology?" J Mol Diagn 3: 92—7.[Free Full Text]

Lakhani, S.R. and A. Ashworth (2001). "Microarray and Histopathological Analysis of Tumours: The Future and the Past?" Nature Rev Cancer 2: 151—7.

Liefers, G.J. and R.A. Tollenaar (2002). "Cancer Genetics and Their Application to Individualised Medicine." Eur J Cancer 38: 872—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Negm, R.S., M. Verma, and S. Srivastava (2002). "The Promise of Biomarkers in Cancer Screening and Detection." Trends Mol Med 8: 288—93.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Petricoin, E.F. 3rd, J.L. Hackett, L.J. Lesko, et al. (2002). "Medical Applications of Microarray Technologies: A Regulatory Science Perspective." Nat Genet 32 (Suppl): 474—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Ramaswamy, S. and T.R. Golub (2002). "DNA Microarrays in Clinical Oncology." J Clin Oncol 20: 1932—41.[Abstract/Free Full Text]

Ramaswamy, S. and C.M. Perou (2003). "DNA Microarrays in Breast Cancer: The Promise of Personalised Medicine." Lancet 361: 1576—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Ransohoff, D.F. (2003). "Developing Molecular Biomarkers for Cancer." Sciencept 299: 1679—80.

Schatzkin, A. and M. Gail (2002). "The Promise and Peril of Surrogate End Points in Cancer Research." Nat Rev Cancer 2: 19—27.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Shi, H., S. Maier, I. Nimmrich, et al. (2003). "Oligonucleotide-Based Microarray for DNA Methylation Analysis: Principles and Applications." J Cell Biochem 88: 138—43.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Sidransky, D. (2002). "Emerging Molecular Markers of Cancer," Nature Rev Cancer 3: 210—9.

Srinivas, P.R., S. Srivastava, S. Hanash, and G.L. Wright Jr (2001). "Proteomics in Early Detection of Cancer," Clin Chem 10: 1901—11.

Steimer, W. and J.M. Potter (2002). "Pharmacogenetic Screening and Therapeutic Drugs." Clin Chim Acta 1—2: 137—55.

Sturgeon, C. (2002). "Practice Guidelines for Tumor Marker Use in the Clinic." Clin Chem 48: 1151—9.[Abstract/Free Full Text]

Ubel, P.A., C. Jepson, J. Baron, et al. (2003). "The Influence of Cost-Effectiveness Information on Physicians' Cancer Screening Recommendations." Soc Sci Med 56: 1727—36.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

van de Vijver, M.J., Y.D. He, L.J. van't Veer, et al. (2002). "Gene-Expression Signature as a Predictor of Survival in Breast Cancer." N Engl J Med 19: 1999—2009.

Verma, M. and S. Srivastava (2002). "Epigenetics in Cancer: Implications for Early Detection and Prevention." Lancet Oncol 3: 755—63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]